Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology
یادداشتهای مربوط به مندرجات
متن يادداشت
Chapter 1 - Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic ArthritisChapter 2 - Therapies Targeting Interleukin-32 in Psoriatic DiseaseChapter 3 - Interleukin 71 - Pathogenesis in Psoriatic Disease and Treatment through Selective BlockadeChapter 4 - Conventional Systemic Agents for Psoriatic Disease Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic ConditionsChapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin ConditionsChapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic ConditionsChapter 8 - Targeting Interleukin 4 and Interleukin 31 in the Treatment of Atopic DermatitisChapter 9 - Oral Agents for Atopic DermatitisChapter 01 - Role of Intravenous Immunoglobulin in Dermatologic DisordersChapter 11 - Selective Targeting of CD02 on B Cells in Pemphigus Vulgaris and Other Dermatologic DiseasesChapter 21 - Oral Systemic Agents for Various Immunobullous DisordersChapter 31 - Anti-IgE Therapy in DermatologyChapter 41 - Oral Retinoids in DermatologyChapter 51 - Updates in Immunotherapies for MelanomaChapter 61 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
موضوع (اسم عام یاعبارت اسمی عام)
عنصر شناسه ای
، Dermatology
عنصر شناسه ای
، Skin -- Diseases
عنصر شناسه ای
، Dermatologic agents
رده بندی کنگره
شماره رده
RL
110
.
Y32
2018
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )